Skip to main content

Table 3 Other outcomes including adverse events

From: Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial

Variable Group A Group B P value
Ecchymoses morbidity 7 38 0.001
Area of ecchymoses(%)b 1.6 ± 0.7 3.0 ± 1.3 0.001
 Symptomatic DVT 0 0 NA
 Asymptomatic DVT 5 3 0.50
 Superficial infection 0 0 1.00
 Deep infection 0 0 NA
 Hematoma 0 0 NA
 Wound secretion 2 1 0.58
30-day mortality 0 0 NA
90-day readmission 0 0 NA
Satisfaction level
 Extremely satisfied 21 18 0.88
 Very satisfied 19 17  
 Somewhat satisfied 12 11  
 Neither satisfied nor dissatisfied 7 10  
 Somewhat dissatisfied 1 2  
 Very dissatisfied 0 0